Skip to content

Dry Needling With And Without Kinesio Taping® in The Non-Specific Chronic Low Back Pain

Comparing Dry Needling With And Without Kinesio Taping® in The Treatment of Non-Specific Chronic Low Back Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04170816
Enrollment
60
Registered
2019-11-20
Start date
2019-12-01
Completion date
2020-03-01
Last updated
2019-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Spesific Chronic Low Back Pain

Keywords

Dry needling, Kinesiotape, Low-back pain

Brief summary

We wiil evaluate the efficiency of adding kinesio taping (KT) therapy to dry needling (DN) therapy on pain, functionality and depression parameters in 60 patients with nonspecific chronic low back pain (nCLBP).

Detailed description

A total of 60 patients will be included in the study. 30 patients will be in the treatment group and 30 patients will be in the control group. Both groups will be underwent 3 sessions with 1-week intervals on active myofascial trigger points in lumbar multifidus, quadratus lumborum and gluteus medius muscles in DN therapy. KT application will be performed after every DN session in the study group. Pain will evaluate with visual analog scale, functionality was evaluated with Oswestry Disability Index and the status of depression will be evaluated with Beck Depression Index before the treatment and at the first month.

Interventions

DEVICEDry needling

DN and KT therapy will be applied 3 sessions in 1-week intervals

Sponsors

Kars State Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* having no abnormal results in routine blood tests * having no known acute or chronic inflammatory disease * an education level required for understanding the applied treatment, interventions

Exclusion criteria

* malignancies * active infection * history of common inflammatory rheumatic disease * trauma in spinal area, skin lesion, presence of infection or open wounds * radiculopathy * peripheral circulation disorder * use of warfarin due to coagulopathy * arthropathy * congenital or acquired spinal pathology * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Pain pressure threshold3 weekAmount of pressure (Kg/cm2) applied at the lomber multifidus muscle, quadratus lumborum and gluteus medius muscle myofascial trigger point site that elicit pain for the patient will be reported
Pain by visual analog scale (VAS)3 weekVisual analog scale (VAS,0-10) will be used to assess resting, activity and night pain.
Oswestry disability Index (ODI)3 weekChanges from the Baseline, ODI is an effective tool to provide information on the extent of backache affecting the patient ability to cope with tasks of everyday life. Ten sections are included in the ODI tool with a total possible score of 5 for each section. The first statement carries a score of 0, and the last has a score of 5.
Beck Depression Inventory3 weekThis is a 21-item standard assessment used to measure clinical depression. Scores on this assessment range from 0 to 63, where higher scores indicate higher levels of depression.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026